Abstract
The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Current Stem Cell Research & Therapy
Title:Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection
Volume: 10 Issue: 3
Author(s): Lin Cheng, Yong Zhang, Yuemin Nan and Liang Qiao
Affiliation:
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Abstract: The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Export Options
About this article
Cite this article as:
Cheng Lin, Zhang Yong, Nan Yuemin and Qiao Liang, Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666140923121234
DOI https://dx.doi.org/10.2174/1574888X09666140923121234 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Current Stem Cell Research & Therapy Interferon Treatment in Patients with Hypereosinophilia
Current Drug Targets Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer
Current Genomics Recent Research Progress on Magnetic Nanocomposites with Silica Shell Structures Preparation and Nanotheranostic Applications
Recent Patents on Nanotechnology Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives
Current Pharmaceutical Biotechnology Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery Viral Proteases as Targets for Drug Design
Current Pharmaceutical Design Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?
Current Stem Cell Research & Therapy LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
Current Gene Therapy Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design
Current Pharmaceutical Design Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma
Current Cancer Drug Targets Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms
Current Pharmacogenomics What Does Systems Biology Mean for Drug Development?
Current Medicinal Chemistry Nanoscale Functional Biomaterials for Cancer Theranostics
Current Medicinal Chemistry Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets